Profiel
Danielle Glenn served as the Chief Investment Officer at OrbiMed Advisors LLC.
She then worked as the Chief Financial Officer at Arctic Bioscience AS from 2020 to 2022.
Following that, she held the position of Chief Investment Officer at Bywater Capital Ltd. In 2022, she became the Chief Financial Officer & Head-Investor Relations at Zwipe AS.
Ms. Glenn completed her undergraduate degree at Harvard University.
Eerdere bekende functies van Danielle Glenn
| Bedrijven | Functie | Einde |
|---|---|---|
| ZWIPE | Financieel Directeur/CFO | 01-02-2024 |
| ARCTIC BIOSCIENCE | Financieel Directeur/CFO | 31-03-2022 |
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Chief Investment Officer | - |
Bywater Capital Ltd. | Chief Investment Officer | - |
Opleiding van Danielle Glenn
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zwipe AS
Zwipe AS Computer PeripheralsElectronic Technology Develops and markets biometric contactless payment cards | Electronic Technology |
Arctic Bioscience AS
Arctic Bioscience AS Pharmaceuticals: MajorHealth Technology Manufactures and wholesales nutraceutical & pharmaceutical products | Health Technology |
Bywater Capital Ltd. |
















